Andrew Gillman

The Melbourne epidemic thunderstorm asthma event 2016: an investigation of environmental triggers, effect on health services, and patient risk factors

Francis Thien, Paul J. Beggs, Danny Csutoros et al. · The Lancet Planetary Health · 2018 · 255 citations · Full text

Mepolizumab effectiveness and identification of super-responders in severe asthma

Erin S. Harvey, David Langton, Constance H. Katelaris et al. · European Respiratory Journal · 2020 · 189 citations · Full text

Clinical Efficacy and Immunologic Effects of Omalizumab in Allergic Bronchopulmonary Aspergillosis

Astrid Voskamp, Andrew Gillman, Karen Symons et al. · The Journal of Allergy and Clinical Immunology In Practice · 2015 · 174 citations

Allergy, Inflammatory Lung Disease, Allergic Bronchopulmonary Aspergillosis +9

Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry

Peter G. Gibson, Helen K. Reddel, Vanessa M. McDonald et al. · Internal Medicine Journal · 2016 · 81 citations

The 2016 Melbourne thunderstorm asthma epidemic: Risk factors for severe attacks requiring hospital admission

Mark Hew, Joy Lee, Nugroho Harry Susanto et al. · Allergy · 2018 · 78 citations